Two new non-competitive mGlu1 receptor antagonists are potent tools to unravel functions of this mGlu receptor subtype

Br J Pharmacol. 2007 Jul;151(6):723-4. doi: 10.1038/sj.bjp.0707289. Epub 2007 May 14.

Abstract

The validation of the selective, potent and systemically active non-competitive mGlu1 antagonists YM-298198 and JNJ16259685 in a physiological functional assay will facilitate elucidation of this receptor's role in brain function and as a potential drug target.

MeSH terms

  • Benzimidazoles / pharmacology*
  • Brain / physiology
  • Drug Delivery Systems
  • Electrophysiology
  • Humans
  • Quinolines / pharmacology*
  • Receptors, Metabotropic Glutamate / antagonists & inhibitors*
  • Receptors, Metabotropic Glutamate / physiology
  • Synaptic Transmission
  • Thiazoles / pharmacology*

Substances

  • (3,4-dihydro-2H-pyrano(2,3)b-quinolin-7-yl)-(cis-4-methoxycyclohexyl) methanone
  • 6-amino-N-cyclohexyl-N,3-dimethylthiazolo(3,2-a)benzimidazole-2-carboxamide
  • Benzimidazoles
  • Quinolines
  • Receptors, Metabotropic Glutamate
  • Thiazoles
  • metabotropic glutamate receptor type 1